5J1V

Crystal structure of human CLK1 in complex with pyrido[3,4-g]quinazoline derivative ZW29 (compound 13)

Summary for 5J1V

• Entry DOI: 10.2210/pdb5j1v/pdb
• Descriptor: Dual specificity protein kinase CLK1, pyrido[3,4-g]quinazoline-2,10-diamine, GLYCEROL, ... (4 entities in total)
• Functional Keywords: transferase, serine/threonine-protein kinase, tyrosine-protein kinase, nucleus, inhibitor, structural genomics consortium, sgc
• Biological source: Homo sapiens (Human)
• Cellular location: Nucleus: P49759
• Total number of polymer chains: 3
• Total formula weight: 119562.39

Authors

Chaikuad, A.,Esvan, Y.J.,Zeinyeh, W.,Boibessot, T.,Nauton, L.,Thery, V.,Loaec, N.,Meijer, L.,Giraud, F.,Moreau, P.,Anizon, F.,von Delft, F.,Bountra, C.,Arrowsmith, C.H.,Edwards, A.M.,Knapp, S.,Structural Genomics Consortium (SGC) (deposition date: 2016-03-29, release date: 2016-05-04, Last modification date: 2024-01-10)

• Primary citation: Esvan, Y.J.,Zeinyeh, W.,Boibessot, T.,Nauton, L.,Thery, V.,Knapp, S.,Chaikuad, A.,Loaec, N.,Meijer, L.,Anizon, F.,Giraud, F.,Moreau, P.; Discovery of pyrido[3,4-g]quinazoline derivatives as CMGC family protein kinase inhibitors: Design, synthesis, inhibitory potency and X-ray co-crystal structure.; Eur.J.Med.Chem., 118:170-177, 2016; PubMed: 27128181; DOI: 10.1016/j.ejmech.2016.04.004

Experimental method

X-RAY DIFFRACTION (2.52 Å)